呼吸系统急性疾病患者居家医院级照护:描述性分析
该回顾性研究分析2017-2021年居家医院(HH)照护的1031例患者,其中24%因呼吸系统疾病入院。
要点
- 呼吸疾病患者居家医院照护的住院时间、检查与静脉用药使用少于其他内科患者。
- 出院30天内再入院、急诊就诊和死亡率两组相似。
核心结论
- 居家医院照护对急性呼吸系统疾病患者与其他急性内科疾病患者同样安全有效。
研究设计与样本
- 回顾性评估前瞻性收集的2017-2021年居家医院照护患者数据,共分析1031例,24%因呼吸疾病入院。
主要发现
- 呼吸疾病患者住院时间平均3.4天 vs 其他4.6天,实验室检查中位数0 vs 2,静脉用药43% vs 73%,专科会诊2% vs 7%(P均<.001)。
关键数值与推荐
- 呼吸疾病入院原因包括哮喘急性发作(26%)、慢阻肺急性加重(33%)和非COVID-19肺炎(41%)。
- 居家医院照护期间每日两次护士访视和一次医生访视,提供静脉药物、高级呼吸治疗及持续心率和呼吸频率监测。
临床怎么用
- 对符合条件的急性呼吸疾病患者,可考虑以居家医院照护替代传统住院,以释放医疗系统容量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Home hospital (HH) care is hospital-level substitutive care delivered at home for acutely ill patients who traditionally would be cared for in the hospital. Despite HH care programs operating successfully for years and scientific evidence of similar or better outcomes compared with bricks-and-mortar care, HH care outcomes in the United States for respiratory disease have not been evaluated. RESEARCH QUESTION: Do outcomes differ between patients admitted to HH care with acute respiratory illness vs those with other acute general medical conditions? STUDY DESIGN AND METHODS: This was a retrospective evaluation of prospectively collected data of patients admitted to HH care (2017-2021). We compared patients requiring admission with respiratory disease (asthma exacerbation [26%], acute exacerbation of COPD [33%], and non-COVID-19 pneumonia [41%]) to all other patients admitted to HH care. During HH care, patients received two nurse and one physician visit daily, IV medications, advanced respiratory therapies, and continuous heart and respiratory rate monitoring. Main outcomes were acute and postacute health care use and safety. RESULTS: We analyzed 1,031 patients; 24% were admitted for respiratory disease. Patients with and without respiratory disease were similar: mean age, 68 ± 17 years, 62% women, and 48% White. Patients with respiratory disease more often were active smokers (21% vs 9%; P < .001). Eighty percent of patients showed an FEV1 to FVC ratio of ≤ 70; 28% showed a severe or very severe obstructive pattern (n = 118). During HH care, patients with respiratory disease showed less health care use: length of stay (mean, 3.4 vs 4.6 days), laboratory orders (median, 0 vs 2), IV medication (43% vs 73%), and specialist consultation (2% vs 7%; P < .001 for all). Ninety-six percent of patients completed the full admission at home with no mortality in the respiratory group. Within 30 days of discharge, both groups showed similar readmission, ED presentation, and mortality rates. INTERPRETATION: HH care is as safe and effective for patients with acute respiratory disease as for those with other acute general medical conditions. If scaled, it can generate significant high-value capacity for health systems and communities, with opportunities to advance the complexity of care delivered.
引用
- Hernandez, Tukpah, Mitchell, et al. Hospital-Level Care at Home for Patients With Acute Respiratory Disease: A Descriptive Analysis. Chest. 2022. PMID: 36372302. doi:10.1016/j.chest.2022.11.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。